feed,title,long_url,short_url
MarketWatch,NIH recommends Lilly and Regeneron's combination antibody treatments to people with mild and moderate COVID-19,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/sobeqdQA4Ck/story.aspx,https://on.mktw.net/3dQn9Ro
